Amla

Last Updated: September 28 2022

Emblica officinalis (Amla) is an ayurvedic herb which has all parts, including the fruits, used for preventative and therapeutic purposes. It appears to be most used for regulating glucose metabolism and cardiac health, and may also be neuroprotective.

Amla is most often used for

Summary

Emblica officinalis (also referred to as Phyllanica emblica or simply as Amla) is a herb from Indian medicine (Ayurveda) that has traditionally been used for the purposes of enhancing general vitality and cognition as well as promoting longevity; a goal similar to adaptogen compounds (although an adaptogenic effect has not clearly been demonstrated with Amla).

There is very limited human evidence on Amla at this moment in time, but it appears to be very promising as it could lower blood glucose in both healthy persons and diabetics with a potency similar to the reference drug glibenclamide. In animal research, amla appears to be able to reduce triglycerides and better the cholesterol profile as well as benefit cardiovascular health (the heart and vessels themselves). Most of these actions are attributed to its antioxidant properties, which are partially derived from a high Vitamin C content but also from a large amount of tannin compounds that are also found in other potent antioxidants like camellia sinsensis (the plant that bears green tea catechins) and dimocarpus longan.

Along the more interesting but preliminary research is a hair growth promoting effect that exceeds that of minoxidil, and a longevity promoting effect in fruit flies that (while not directly compared against other agents) appears to be more effective than other nutraceutical options.

While there is not enough evidence to recommend Amla for any particular purpose, it appears to possess a wide spectrum of potential benefits that require further research and may contribute to general well being and longevity as insinuated in traditional medicine.

What else is Amla known as?
Note that Amla is also known as:
  • Phyllanthus Emblica
  • Amla
  • Anwala
  • Indian Gooseberry
  • Emblica Officinalis
Dosage information

Unless otherwise specified, most benefits associated with emblica officinalis are from the fruits of the plant. The fruits themselves (dry weight) or their powder are taken in the dosage range of 1-3g daily with the higher part of this range being seen as more effective.

Join our supplement information course

Enter your email for a FREE five-day course on supplements. Get only the information that’s 100% backed by science. We take an independent and unbiased approach to figure out what works (and what’s a waste of time and money).

Examine is the only 100% independent company in the nutrition and supplement industry. While everyone else sells supplements and works with sponsors, we exclusively analyze research.

    The only 100% independent company. While everyone sells supplements, we only analyze research.

    Don't miss out on the latest research

    Become an Examine Insider for FREE to stay on top of the latest nutrition research, supplement myths, and more

      References
      1.^Manjunatha S, Jaryal AK, Bijlani RL, Sachdeva U, Gupta SKEffect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profileIndian J Physiol Pharmacol.(2001 Jan)
      7.^Ali SK, Hamed AR, Soltan MM, Hegazy UM, Elgorashi EE, El-Garf IA, Hussein AAIn-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer diseaseBMC Complement Altern Med.(2013 May 30)
      10.^Judprasong K, Charoenkiatkul S, Thiyajai P, Sukprasansap MNutrients and bioactive compounds of Thai indigenous fruitsFood Chem.(2013 Oct 1)
      11.^Chatterjee UR, Bandyopadhyay SS, Ghosh D, Ghosal PK, Ray BIn vitro anti-oxidant activity, fluorescence quenching study and structural features of carbohydrate polymers from Phyllanthus emblicaInt J Biol Macromol.(2011 Nov 1)
      14.^Chang KC, Laffin B, Ponder J, Enzsöly A, Németh J, LaBarbera DV, Petrash JMBeta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissuesChem Biol Interact.(2013 Feb 25)
      15.^Amaravani M, Prasad NK, Ramakrishna VCOX-2 structural analysis and docking studies with gallic acid structural analoguesSpringerplus.(2012 Dec)
      16.^She G, Cheng R, Sha L, Xu Y, Shi R, Zhang L, Guo YA novel phenolic compound from Phyllanthus emblicaNat Prod Commun.(2013 Apr)
      17.^Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LRAmla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing processBr J Nutr.(2007 Jun)
      20.^Suryanarayana P, Saraswat M, Petrash JM, Reddy GBEmblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in ratsMol Vis.(2007 Jul 24)
      21.^Chularojmontri L, Suwatronnakorn M, Wattanapitayakul SKPhyllanthus emblica L. Enhances Human Umbilical Vein Endothelial Wound Healing and SproutingEvid Based Complement Alternat Med.(2013)
      22.^Kamali SH, Khalaj AR, Hasani-Ranjbar S, Esfehani MM, Kamalinejad M, Soheil O, Kamali SAEfficacy of 'Itrifal Saghir', a combination of three medicinal plants in the treatment of obesity; A randomized controlled trialDaru.(2012 Sep 10)
      27.^Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu NEmblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in ratsJ Med Food.(2011 Jan-Feb)
      28.^Liang LP, Patel MSeizure-induced changes in mitochondrial redox statusFree Radic Biol Med.(2006 Jan 15)
      33.^Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SKAntioxidant activity of active tannoid principles of Emblica officinalis (amla)Indian J Exp Biol.(1999 Jul)
      36.^Ojha S, Golechha M, Kumari S, Arya DSProtective effect of Emblica officinalis (amla) on isoproterenol-induced cardiotoxicity in ratsToxicol Ind Health.(2012 Jun)
      37.^Wongpradabchai S, Chularojmontri L, Phornchirasilp S, Wattanapitayakul SKProtective effect of Phyllanthus emblica fruit extract against hydrogen peroxide-induced endothelial cell deathJ Med Assoc Thai.(2013 Jan)
      39.^Bhatia J, Tabassum F, Sharma AK, Bharti S, Golechha M, Joshi S, Sayeed Akhatar M, Srivastava AK, Arya DSEmblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stressCardiovasc Toxicol.(2011 Sep)
      40.^Nampoothiri SV, Prathapan A, Cherian OL, Raghu KG, Venugopalan VV, Sundaresan AIn vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetesFood Chem Toxicol.(2011 Jan)
      42.^Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DVThe isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalisPLoS One.(2012)
      45.^Chlubek D, Grucka-Mamczar E, Birkner E, Polaniak R, Stawiarska-Pieta B, Duliban HActivity of pancreatic antioxidative enzymes and malondialdehyde concentrations in rats with hyperglycemia caused by fluoride intoxicationJ Trace Elem Med Biol.(2003)
      46.^Vasant RA, Narasimhacharya AVAmla as an antihyperglycemic and hepato-renal protective agent in fluoride induced toxicityJ Pharm Bioallied Sci.(2012 Jul)
      49.^Faizal P, Suresh S, Satheesh Kumar R, Augusti KTA study on the hypoglycemic and hypolipidemic effects of an ayurvedic drug Rajanyamalakadi in diabetic patientsIndian J Clin Biochem.(2009 Jan)
      50.^Chen TS, Liou SY, Wu HC, Tsai FJ, Tsai CH, Huang CY, Chang YLEfficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) extract for the treatment of diabetic-uremic patientsJ Med Food.(2011 Jul-Aug)
      51.^Kalekar SA, Munshi RP, Bhalerao SS, Thatte UMInsulin sensitizing effect of 3 Indian medicinal plants: an in vitro studyIndian J Pharmacol.(2013 Jan-Feb)
      52.^Kumar N, Rungseevijitprapa W, Narkkhong NA, Suttajit M, Chaiyasut C5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatmentJ Ethnopharmacol.(2012 Feb 15)
      53.^Bhatnagar A, Srivastava SKAldose reductase: congenial and injurious profiles of an enigmatic enzymeBiochem Med Metab Biol.(1992 Oct)
      54.^Gabbay KHThe sorbitol pathway and the complications of diabetesN Engl J Med.(1973 Apr 19)
      55.^Ghahary A, Luo JM, Gong YW, Chakrabarti S, Sima AA, Murphy LJIncreased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic ratsDiabetes.(1989 Aug)
      57.^Ramana KV, Reddy AB, Tammali R, Srivastava SKAldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophagesFree Radic Biol Med.(2007 Apr 15)
      58.^Ramana KV, Fadl AA, Tammali R, Reddy AB, Chopra AK, Srivastava SKAldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophagesJ Biol Chem.(2006 Nov 3)
      61.^Majeed M, Bhat B, Anand S, Sivakumar A, Paliwal P, Geetha KGInhibition of UV-induced ROS and collagen damage by Phyllanthus emblica extract in normal human dermal fibroblastsJ Cosmet Sci.(2011 Jan-Feb)
      62.^Adil MD, Kaiser P, Satti NK, Zargar AM, Vishwakarma RA, Tasduq SAEffect of Emblica officinalis (fruit) against UVB-induced photo-aging in human skin fibroblastsJ Ethnopharmacol.(2010 Oct 28)
      63.^Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PLScientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a reviewChin J Integr Med.(2012 Dec)